Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 55101-55150 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04802174
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
PHASE1/PHASE2Recruiting
120 participants
Started: Jun 1, 2021 · Completed: Dec 1, 2027
4 conditions1 sponsor1 location
NCT06722768
Identifying Gait Changes From a CSF Tap Test Using a Smart Insole in iNPH
N/ARecruiting
50 participants
Started: Jun 1, 2021 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT06455163
Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers
NARecruiting
102 participants
Started: Jun 1, 2021 · Completed: May 31, 2026
1 condition3 sponsors1 location
NCT04988685
SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon Catheters
N/ARecruiting
2,000 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2031
10 conditions2 sponsors1 location
NCT04984304
Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough
NARecruiting
150 participants
Started: Jun 1, 2021 · Completed: May 31, 2024
5 conditions1 sponsor1 location
NCT05059158
Amyloid-β Clearance Mechanisms in Alzheimer's Disease
N/ARecruiting
60 participants
Started: Jun 1, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04935021
Clinical Study of ATTR-CM
PHASE4Recruiting
100 participants
Started: Jun 1, 2021 · Completed: Jun 1, 2031
1 condition1 sponsor1 location
NCT04901884
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
NARecruiting
40 participants
Started: Jun 1, 2021 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04832178
Sumor as Adjuvant Therapy in Treatment-resistant Major Depression
PHASE4Recruiting
102 participants
Started: Jun 1, 2021 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT04675073
Preventive VT Substrate Ablation in Ischemic Heart Disease
PHASE3Recruiting
58 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT04671862
Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis
NARecruiting
25 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04396483
Dysfunctional Uterine Bleeding After Tubal Sterilization
NARecruiting
220 participants
Started: Jun 1, 2021 · Completed: Mar 31, 2024
2 conditions1 sponsor2 locations
NCT04105231
Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
PHASE2Recruiting
64 participants
Started: Jun 1, 2021 · Completed: Jun 30, 2025
1 condition5 sponsors1 location
NCT04617184
Registry and Biorepository for IBD in Central Texas
N/ARecruiting
1,000 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2030
3 conditions1 sponsor1 location
NCT04987086
68Ga-PSMA PET in the Renal Cell Carcinoma
NARecruiting
300 participants
Started: Jun 1, 2021 · Completed: Jun 1, 2025
3 conditions1 sponsor1 location
NCT04760522
Genome-based Management of Patients in Precision Medicine (Ge-Med) Towards a Genomic Health Program
NARecruiting
12,000 participants
Started: Jun 1, 2021 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05058937
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
NARecruiting
936 participants
Started: Jun 1, 2021 · Completed: May 31, 2026
2 conditions4 sponsors12 locations
NCT04980716
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
PHASE3Recruiting
524 participants
Started: Jun 1, 2021 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location
NCT04653896
A Powered Exoskeleton for Veterans With Knee OA
NARecruiting
26 participants
Started: Jun 1, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT04656951
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
PHASE2Recruiting
160 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT05115656
Online Intervention for Traumatic Brain Injury Wellbeing
NARecruiting
60 participants
Started: Jun 1, 2021 · Completed: Dec 31, 2023
3 conditions2 sponsors1 location
NCT03660917
Riluzole in Patients With Spinocerebellar Ataxia Type 7
PHASE2/PHASE3Recruiting
34 participants
Started: Jun 1, 2021 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT04776265
RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT
N/ARecruiting
100 participants
Started: Jun 1, 2021 · Completed: Apr 1, 2024
3 conditions2 sponsors15 locations
NCT04984473
A Study to Evaluate Breathing Muscle Training in Cardiac Rehab
NARecruiting
42 participants
Started: Jun 1, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06146972
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
PHASE4Recruiting
117 participants
Started: Jun 1, 2021 · Completed: May 31, 2024
2 conditions1 sponsor1 location
NCT04626167
Concomitant Renal and Urinary Bladder Allograft Transplantation
EARLY_PHASE1Recruiting
30 participants
Started: Jun 1, 2021 · Completed: Jan 31, 2026
9 conditions1 sponsor2 locations
NCT04137835
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
NARecruiting
60 participants
Started: Jun 1, 2021 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04906187
Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery
NARecruiting
126 participants
Started: May 31, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04859725
HyperSpectral Imaging in Low Grade Glioma
NARecruiting
10 participants
Started: May 31, 2021 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT04959604
Lymph Node Mapping Via Flourescent Dye in Colon Cancer
NARecruiting
30 participants
Started: May 31, 2021 · Completed: Dec 30, 2026
2 conditions1 sponsor1 location
NCT04898283
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
PHASE3Recruiting
180 participants
Started: May 31, 2021 · Completed: Oct 31, 2026
3 conditions1 sponsor27 locations
NCT04945304
9-Step Magnetic Bariatric Revisional Surgery
N/ARecruiting
500 participants
Started: May 31, 2021 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT04649125
Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation
NARecruiting
100 participants
Started: May 31, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
110 participants
Started: May 31, 2021 · Completed: Dec 31, 2025
5 conditions1 sponsor6 locations
NCT06330298
Improving Social Cognition and Social Behaviour in Various Brain Disorders
NARecruiting
84 participants
Started: May 31, 2021 · Completed: Jan 31, 2025
3 conditions1 sponsor2 locations
NCT04770116
Auditory Slow Wave Enhancement After Concussion
NARecruiting
120 participants
Started: May 31, 2021 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT04908566
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
124 participants
Started: May 31, 2021 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT04890041
TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years
NARecruiting
100 participants
Started: May 30, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06260436
Questionnaire of Lower Urinary Tract Symptoms Among Women Before and After Surgical Correction of Uterine Prolapse
N/ARecruiting
180 participants
Started: May 30, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT07077382
Pneumoconiosis and Dust Exposure China Cohort
N/ARecruiting
2,000 participants
Started: May 28, 2021 · Completed: May 31, 2030
1 condition11 sponsors1 location
NCT04864158
Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy
NARecruiting
102 participants
Started: May 28, 2021 · Completed: Nov 30, 2038
1 condition11 sponsors8 locations
NCT04432662
Darbepoetin in Neonatal Encephalopathy Trial
PHASE2Recruiting
150 participants
Started: May 28, 2021 · Completed: Sep 1, 2024
1 condition1 sponsor9 locations
NCT04768647
Vestibulopathy as a Cause of Imbalance in Parkinson
PHASE1/PHASE2Recruiting
64 participants
Started: May 28, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors2 locations
NCT04895020
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
PHASE3Recruiting
1,200 participants
Started: May 28, 2021 · Completed: May 31, 2026
15 conditions2 sponsors1 location
NCT04993235
Body Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development
N/ARecruiting
92 participants
Started: May 28, 2021 · Completed: Dec 31, 2023
5 conditions2 sponsors1 location
NCT04912518
Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
NARecruiting
250 participants
Started: May 27, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors9 locations
NCT04789486
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
PHASE1/PHASE2Recruiting
100 participants
Started: May 27, 2021 · Completed: Sep 10, 2027
4 conditions2 sponsors2 locations
NCT04606914
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2Recruiting
70 participants
Started: May 27, 2021 · Completed: May 31, 2028
3 conditions1 sponsor9 locations
NCT04283604
The Effects of a Single Dose of Methylphenidate on Motor Performance
PHASE4Recruiting
200 participants
Started: May 27, 2021 · Completed: Mar 31, 2024
1 condition3 sponsors1 location
NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
949 participants
Started: May 27, 2021 · Completed: Jul 7, 2028
11 conditions1 sponsor50 locations